Literature DB >> 11276384

Photodynamic therapy in the biliary tract.

M Ortner1.   

Abstract

Biliary tract cancers are rare malignancies usually characterized by slow growth and a low propensity for metastasis. Despite the relatively localized nature of these cancers, the only therapeutic measure with curative potential to date is surgical intervention. Because symptoms occur late, the diagnosis is rarely made at an early stage, and therefore only about half of the patients can have curative surgery. Patients with advanced disease face a dismal prognosis because palliative treatment options are limited. This review outlines recent advances in treatment of biliary cancer. Encouraging results from prospective, single-arm phase II trials of photodynamic therapy in nonresectable cholangiocarcinoma suggest considerable promise for this new palliative treatment modality. However, the apparent benefit of photodynamic therapy on survival, jaundice, and quality of life must be confirmed in a randomized multicenter trial.

Entities:  

Mesh:

Year:  2001        PMID: 11276384     DOI: 10.1007/s11894-001-0013-8

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


  46 in total

1.  The use of a derivative of hematoporhyrin in tumor detection.

Authors:  R L LIPSON; E J BALDES; A M OLSEN
Journal:  J Natl Cancer Inst       Date:  1961-01       Impact factor: 13.506

2.  Symptom relief and quality of life after stenting for malignant bile duct obstruction.

Authors:  A B Ballinger; M McHugh; S M Catnach; E M Alstead; M L Clark
Journal:  Gut       Date:  1994-04       Impact factor: 23.059

3.  Orthotopic liver transplantation after extended bile duct resection as treatment of hilar cholangiocarcinoma. First long-terms results.

Authors:  S Jonas; N Kling; O Guckelberger; H Keck; W O Bechstein; P Neuhaus
Journal:  Transpl Int       Date:  1998       Impact factor: 3.782

4.  Palliation of proximal malignant biliary obstruction by endoscopic endoprosthesis insertion.

Authors:  A A Polydorou; S R Cairns; J F Dowsett; A R Hatfield; P R Salmon; P B Cotton; R C Russell
Journal:  Gut       Date:  1991-06       Impact factor: 23.059

5.  Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors.

Authors:  A Nakeeb; H A Pitt; T A Sohn; J Coleman; R A Abrams; S Piantadosi; R H Hruban; K D Lillemoe; C J Yeo; J L Cameron
Journal:  Ann Surg       Date:  1996-10       Impact factor: 12.969

6.  Randomised trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstruction.

Authors:  P H Davids; A K Groen; E A Rauws; G N Tytgat; K Huibregtse
Journal:  Lancet       Date:  1992 Dec 19-26       Impact factor: 79.321

7.  Management of malignant hilar biliary obstruction by endoscopy. Results and prognostic factors.

Authors:  M Ducreux; C Liguory; J F Lefebvre; O Ink; A Choury; J Fritsch; D Bonnel; S Derhy; J P Etienne
Journal:  Dig Dis Sci       Date:  1992-05       Impact factor: 3.199

8.  Factors influencing postoperative morbidity, mortality, and survival after resection for hilar cholangiocarcinoma.

Authors:  C H Su; S H Tsay; C C Wu; Y M Shyr; K L King; C H Lee; W Y Lui; T J Liu; F K P'eng
Journal:  Ann Surg       Date:  1996-04       Impact factor: 12.969

9.  Risk of extrahepatic bileduct cancer after cholecystectomy.

Authors:  A Ekbom; C C Hsieh; J Yuen; D Trichopoulos; J K McLaughlin; S J Lan; H O Adami
Journal:  Lancet       Date:  1993-11-20       Impact factor: 79.321

10.  Monolobar Caroli's Disease and cholangiocarcinoma.

Authors:  E K Abdalla; C E Forsmark; G Y Lauwers; J N Vauthey
Journal:  HPB Surg       Date:  1999
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.